August 31, 2022 - September 1, 2022
Back to all short courses
Risk-Sharing/Performance-Based Arrangements for Drugs and Other Medical Products (Virtual)
LEVEL: Intermediate
TRACK: Health Policy & Regulatory
LENGTH: 4 Hours | Course runs 2 consecutive days, 2 hours each day
Register Here
07:00AM-09:00AM Pacific Daylight Time (PDT)
15:00PM-17:00PM British Summer Time (BST)
10:00AM–12:00PM Eastern Daylight Time (EDT)
14:00PM-16:00PM Coordinated Universal Time (UTC)
Thursday, 1 September 2022 | Course runs 2 consecutive days, 2 hours per day
07:00AM-09:00AM Pacific Daylight Time (PDT)
15:00PM-17:00PM British Summer Time (BST)
10:00AM–12:00PM Eastern Daylight Time (EDT)
14:00PM-16:00PM Coordinated Universal Time (UTC)
Click for time zone conversion
DESCRIPTION
There is significant and growing interest among both the payers and producers of medical products for arrangements that involve a “pay-for-performance” or “risk-sharing” element. These payment schemes involve a plan by which the performance of the product is tracked in a defined patient population over a specified period of time and the level of reimbursement is tied by formula to the outcomes achieved. Although these agreements have an intrinsic appeal, there can be substantial barriers to their implementation. Issues surrounding theory and practice, including incentives and barriers, will be analyzed along with several examples of performance-based schemes from Europe, the United States, and Australia. A hypothetical case study will be used in an interactive session to illustrate a systematic approach to weighing their applicability and feasibility.
Louis P. Garrison, PhD
Professor Emeritus
The Comparative Health Outcomes, Policy, and Economics Institute Department of Pharmacy
University of Washington
Seattle, WA, USA
Adrian Towse, MA, MPhil
Director Emeritus & Senior Research Fellow
Office of Health Economics
London, UK
Basic Schedule:
4 Hours | Course runs 2 consecutive days, 2 hours each day